Flagship VentureLabs IV LLC

Insider profile

Flagship VentureLabs IV LLC's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
33.54
Quantity 30,437
Value US$1,677,277
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-13 2024-12-13
PrS Proposed sale
30,437
33.54
US$1,677,277 		30,437 33.54 US$1,677,277